Uloric Side Effects Hidden By Takeda, Whistleblower Alleges
A whistleblower lawsuit accuses Takeda Pharmaceuticals of hiding potentially harmful side effects of Uloric, a gout medication. The complaint, filed by Helen Ge, alleges that the Japanese drug maker...
View ArticleSide Effects of Digoxin May Up Risk of Death Among A-Fib Patients: Study
The heart drug digoxin may increase the risk of death when given to patients with atrial fibrillation, according to the findings of a new study. Researchers from the United Kingdom published a study...
View ArticleDigoxin May Increase Death Risk For Heart Failure Patients: Study
Patients suffering from heart failure may face a higher risk of death when they take the heart drug digoxin, according to the findings of new research. In a study published this month in the medical...
View ArticleDigoxin Side Effects May Increase Risk of Death: Study
The findings of a new study suggest that side effects of the heart drug digoxin may reduce the lifespan of patients with atrial fibrillation, increasing the risk of death among users. Stanford...
View ArticleStudy Links Digoxin with 20% Increased Risk of Death
Another new study raises concerns about the potential side effects of digoxin, linking the popular hear drug to an increased risk of death among patients with atrial fibrillation. Researchers from...
View ArticleDigoxin Linked to Increased Risk of Death in A-Fib Patients: Study
Yet another study raises concerns about side effects of digoxin, a popular heart drug, indicating that some users of the medication may face an increased risk of death. According to findings published...
View ArticleDigoxin Side Effects May Increase Risk of Death When Used With Xarelto: Study
The findings of yet another new study appears to indicate that side effects of the heart drug digoxin may increase the risk of death in patients with atrial fibrillation (AF). Researchers from Duke...
View ArticleAnother Study Highlights Link Between Digoxin and Death Risk
A recent review of a several recent studies involving the heart drug digoxin, indicates that the medication does increase the risk of death among certain heart patients, particularly those with atrial...
View ArticleDigoxin Side Effects May Increase Risk of Death In Patients With Atrial...
Duke University researchers indicate that they have uncovered more findings that suggest the side effects of digoxin may cause an increased risk of death among individuals with atrial fibrillation. In...
View ArticleClik here to view.
Digoxin May Increase Risk of Kidney Problems in Heart Failure Patients: Study
Digoxin May Increase Risk of Kidney Problems in Heart Failure Patients: Study Decreased kidney function makes it harder for the body to filter out digoxin, which could cause the heart drug to a...
View ArticleFollowing Digitek Recall, Class Action Suits have been filed
At least two class action suits have been filed on behalf of individuals who used the heart drug Digitek (digoxin). The suits come less than three weeks after all lots of Digitek were recalled on April...
View ArticleDigitek Lawsuits Filed in West Virginia as a Result of Double Strength Tablets
Two West Virginia lawsuits were filed last week as a result of injuries suffered by users who allegedly received Digitek pills that contained twice the approved level of active ingredient. On April 25,...
View ArticleMotion Filed to Consolidate West Virginia Digitek Lawsuits
Lawyers representing individuals who filed Digitek lawsuits in West Virginia state court alleging injuries caused by double strength digoxin tablets which were recalled earlier this year, have filed a...
View ArticleActavis Recalls Over 65 Generic Drugs Made at NJ Plant
On August 1, 2008, Actavis Totowa, LLC announced the recall of over 65 different generic drugs the company manufactured at the same New Jersey plant where they previously produced defective Digitek...
View ArticleFederal Digitek Lawsuits Consolidated in Southern District of West Virginia
The United States Judicial Panel on Multidistrict Litigation has ordered that all Digitek lawsuits filed as a result of allegedly defective and double strength digoxin tablets, be transferred to the...
View ArticleDigitek Litigation: Judge Appoints Lawyers as Plaintiffs’ Co-Liaison Counsel
U.S. District Judge Joseph R. Goodwin, who is overseeing the consolidated Digitek Litigation, appointed two lawyers to serve as Plaintiffs’ Co-Liaison Counsel in the federal MDL formed last month in...
View ArticleDigitek Lawyers Appointed to Leadership Roles in Federal MDL
U.S. District Judge Joseph Goodwin, who is handling the consolidated Digitek lawsuits in West Virginia, has issued a pretrial order appointing Co-Lead Attorneys and members of the Plaintiffs’ Steering...
View ArticleFollowing Recalls, Digitek Manufacturer to Remain Shut Down
The U.S. Department of Justice and the FDA have taken steps to continue barring Actavis Totowa from manufacturing and distributing generic drugs. The actions were taken following a series of serious...
View ArticleDigitek Problems Linked to 667 Deaths
Following Actavis Totowa’s Digitek recall in April 2008, the FDA received a spike in adverse event reports involving the generic digoxin heart drug and it has been identified as the “primary suspect”...
View ArticleActavis Agrees to Keep Digitek Manufacturing Plant Closed
Actavis, Inc. and the FDA agreed last week on a Consent Decree of Permanent Injunction, preventing the drug maker from distributing any products from their Actavis Totowa facility in New Jersey. This...
View ArticleDigitek Recall Lawsuits to be Coordinated Between Federal and State Court
The Digitek recall lawsuits which are currently consolidated in an MDL before Judge Joseph Goodwin in the U.S. District Court for the Southern District of West Virginia will be coordinated with state...
View ArticleDigoxin and Digitek Recall Lawsuits
Digitek brand and generic Digoxin tablets have been recalled due to some pills to contain too much or too little of the active ingredient than is appropriate. This could result in digoxin toxicity,...
View ArticleWatson Propafenone HCL Recall Due to Oversized Tablets
The FDA has posted notice of a Propafenone HCL recall issued by the generic drug maker Watson Pharmaceuticals, Inc., for their 225mg tablets. Some 100 count bottles could have tablets that are...
View ArticleGeneric Digoxin Recall Issued Due to Oversized Tablets
Caraco Pharmaceutical Laboratories has issued a generic digoxin recall after discovering that some pills may have been distributed that contain more or less of the active drug than they should. A...
View ArticleDigoxin Recall Causes Other Generic Drug Makers to Step Up Supply
Following the nationwide recall of Digoxin manufactured by Caraco Pharmaceutical Laboratories, which was issued due to potentially oversized and undersized tablets, other generic drug makers have...
View ArticleDigitek Lawsuit Filed on Behalf of 97 Plaintiffs in Illinois
An Illinois lawsuit has been filed in St. Clair County Circuit Court on behalf of 97 people who allege injuries and damages caused by recalled Digitek tablets that were allegedly manufactured with more...
View ArticleDigoxin Drug Recall Issued by AS Medications Solutions
On May 11, 2009, the FDA posted notice of a digoxin drug recall issued by A S Medication Solutions, LLC, a drug repackaging company who distributed .25mg tablets manufactured by Caraco Pharmaceutical...
View ArticleActavis Digitek Recall Has Resulted in 130 Lawsuits Consolidated in MDL
An additional 23 Digitek lawsuits filed against Actavis Totowa and their distributors in various federal district courts throughout the United States, have been transferred to the U.S. District Court...
View ArticleRecalled Digoxin Manufacturer Raided by US Marshalls and FDA
At the request of the FDA, U.S. Marshals raided generic drug manufacturer Caraco Pharmaceutical Laboratories, Ltd., shutting down manufacturing and seizing inventory. The action came after FDA...
View ArticlePhenobarbital Recall in Canada Due to Oversized Tablets
Health Canada has issued a pms-Phenobarbital recall for 60 milligram tablets of the anxiety and seizure drug distributed by Pharmascience Inc., due to the possibility of that some tablets may be...
View ArticleGeneric Adderall Recall: Oversized Barr Dextroamphetamine/Amphetamine
The FDA and Barr Laboratories, Inc. have announced a recall for generic Adderall tablets that may contain more of the active pharmaceutical ingredients than they are supposed to have, posing a risk of...
View ArticleDigitek Lawsuits Selected for First Trials in Federal MDL
Five Digitek overdose lawsuits have been selected to serve as “bellwether” cases that will lead the way for hundreds of cases filed against Actavis Totowa and distributors of their generic heart drug...
View ArticleFederal and State Judges to Hold Joint Hearing in Digitek Recall Lawsuits
The judges presiding over hundreds of Digitek recall lawsuits in federal court and various states will hold a joint hearing next year to review the scientific evidence in the cases, which involve...
View ArticleDigitek Trial in Federal MDL Scheduled to Begin January 2011
A federal judge presiding over the consolidated Digitek litigation, which is centralized in the U.S. District Court for the Southern District of West Virginia, has scheduled the first trial over the...
View ArticleDigoxin Side Effects Increase Risk of Death for Dialysis Patients: Study
Use of the heart medication digoxin by patients undergoing dialysis treatment has been linked to an increased risk of death, according to recent research. A new retrospective cohort study on the side...
View ArticleDigitek Litigation Stayed Until October by MDL Judge
A federal judge has issued a temporary stay of the Digitek litigation pending in the MDL, halting all proceedings for 75 days in lawsuits filed on behalf of individuals who claim to have suffered...
View ArticleDigitek Settlement Reached to Resolve Lawsuits Over Recalled Heart Drug
A settlement has been reached that will resolve all outstanding state and federal Digitek lawsuits, according to federal court records. On September 1, attorneys for plaintiffs and defendants informed...
View ArticleMetronidazole Recall Issued Due to Undersized Pills
A recall of Metronidazole has been issued by Teva Pharmaceuticals due to potentially undersized pills, which may result in consumers not receiving the full dose of the prescribed antibiotic. The...
View ArticleDigoxin Side Effects Linked to Increased Breast Cancer Risk: Study
According to a new study, the risk of breast cancer may be increased as a side effect of digoxin, a heart drug that is sold as a generic and under the brand names Digitek and Lanoxin. The findings of...
View ArticleFDA Petitioned to Warn About Problems with St John’s Wort Side Effects
A non-profit watchdog group says consumers should be warned that side effects of St. John’s wort could interfere with other drugs, including antidepressants, birth control and blood thinners. The...
View Article